Japanese distributor liable over diabetes products
A Chinese-owned developer of products for diabetes sufferers has applied to a US court to enforce a US$22.6 million ICC award against its Japanese former parent company concerning a terminated distribution deal.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.